-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The human body is made up of countless cells, and each cell needs to replicate its genome when it divides
Studies have reported that in some somatic cells of cancer patients, there are acquired heterozygous missense mutations in the POLE or POLD1 exonuclease domain
Recently, "Nature-Genetics" published online a collaborative study titled "Increased somatic mutation burdens in normal human cells due to defective DNA polymerases" by Michael R.
The researchers recruited 14 patients aged between 17 and 72 who had suffered from colorectal adenoma or colorectal cancer as the study subjects.
At the same time, the researchers also found that colon cancer and endometrial cancer are also common tumors associated with this gene defect
So, can these mutations all have a phenotype? Of course not
All in all, this study shows that multiple normal cell types of carriers of germline mutations in the POLE/POLD1 exonuclease domain exhibit mutation characteristics, which increase the rate of somatic SBS and ID mutations
Reference materials:
[1]https://